• Nexalin signed a 10-year exclusive distribution deal with Inovanexa for the Nexalin Sync device across seven South American countries.
• Inovanexa placed a binding initial purchase order for 10 devices, with five slated for immediate delivery.
• The agreement sets an initial 100-device commercialization program, with a clinical pilot in Brazil targeted within 90 days.
• Local manufacturing in Brazil must be established after 30 devices, funded by the distributor, with per-device payments and disposable electrode royalties to Nexalin.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-010685), on October 01, 2026, and is solely responsible for the information contained therein.